데이터가 없습니다.

1. Association between sarcopenic obesity and poor muscle quality based on muscle quality map and abdominal computed tomography [ Obesity ] - 2023.06.01
2. Association between hypertension and myosteatosis evaluated by abdominal computed tomography [ HYPERTENSION RESEARCH ] - 2023.04.01
3. Association of serum gamma-glutamyl transferase with myosteatosis assessed by muscle quality mapping using abdominal computed tomography [ CLINICAL IMAGING ] - 2023.01.01
4. Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography [ DIABETES & METABOLISM JOURNAL ] - 2023.01.01
5. Free Versus Fixed-Ratio Combination of Basal Insulin and GLP-1 Receptor Agonists in Type 2 Diabetes Uncontrolled With GLP-1 Receptor Agonists: A Systematic Review and Indirect Treatment Comparison [ Frontiers in Endocrinology ] - 2022.05.20
6. Age-Related Associations of Low-Density Lipoprotein Cholesterol and Atherosclerotic Cardiovascular Disease: A Nationwide Population-Based Cohort Study [ JOURNAL OF THE AMERICAN HEART ASSOCIATION ] - 2022.05.03
7. Associations Between the Macular Microvasculatures and Subclinical Atherosclerosis in Patients With Type 2 Diabetes: An Optical Coherence Tomography Angiography Study [ FRONTIERS IN MEDICINE ] - 2022.03.04
8. The Role of Anti-Inflammatory Adipokines in Cardiometabolic Disorders: Moving beyond Adiponectin [ INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES ] - 2021.12.16
9. Prognostic Value of Triglyceride and Glucose Index for Incident Type 2 Diabetes beyond Metabolic Health and Obesity [ ENDOCRINOLOGY AND METABOLISM ] - 2021.10.21
10. Oral Semaglutide, the First Ingestible Glucagon-Like Peptide-1 Receptor Agonist: Could It Be a Magic Bullet for Type 2 Diabetes? [ INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES ] - 2021.09.14
11. The risk of Alzheimer's disease according to dynamic changes in metabolic health and obesity: a nationwide population-based cohort study [ AGING-US ] - 2021.07.08
12. Differential Effect of Metabolic Health and Obesity on Incident Heart Failure: A Nationwide Population-Based Cohort Study [ FRONTIERS IN ENDOCRINOLOGY ] - 2021.02.25
13. C1q/TNF-related protein-9 attenuates palmitic acid-induced endothelial cell senescence via increasing autophagy [ MOLECULAR AND CELLULAR ENDOCRINOLOGY ] - 2021.02.05
14. Metabolic health is a determining factor for incident colorectal cancer in the obese population: A nationwide population-based cohort study [ Cancer Medicine ] - 2021.01.01
15. Impact of Transition in Metabolic Health and Obesity on the Incident Chronic Kidney Disease: A Nationwide Cohort Study [ JOURNAL OF CLINICAL ENDOCRINOLOGY METABOLISM ] - 2020.03.01
16. Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials [ DIABETES & METABOLISM JOURNAL ] - 2019.08.01
17. Implications of the dynamic nature of metabolic health status and obesity on risk of incident cardiovascular events and mortality: a nationwide population-based cohort study [ METABOLISM-CLINICAL AND EXPERIMENTAL ] - 2019.08.01
18. Efficacy and safety of combination therapy with SGLT2 and DPP4 inhibitors in the treatment of type 2 diabetes: A systematic review and meta-analysis [ DIABETES & METABOLISM ] - 2018.11.01
19. Comparison between sodium?glucose cotransporter 2 inhibitors and pioglitazone as additions to insulin therapy in type 2 diabetes patients: A systematic review with an indirect comparison meta-analysis [ Journal of Diabetes Investigation ] - 2018.07.01
20. Effect of SFRP5 (Secreted Frizzled-Related Protein 5) on the WNT5A (Wingless-Type Family Member 5A)-Induced Endothelial Dysfunction and Its Relevance With Arterial Stiffness in Human Subjects. [ ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY ] - 2018.03.28
21. Cardiovascular Diseases and Life Expectancy in Adults With Type 2 Diabetes: A Korean National Sample Cohort Study [ JOURNAL OF CLINICAL ENDOCRINOLOGY METABOLISM ] - 2017.09.01
22. Visceral adiposity index predicts the conversion of metabolically healthy obesity to an unhealthy phenotype. [ PLoS One ] - 2017.06.23
23. Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population [ PLoS One ] - 2017.04.18

1. 대사성 질환에서 단클론 조혈증의 역할 규명 - 2023.03.01 ~ 2024.02.29
2. 서울아산병원 당뇨병 센터의 당뇨병성 족부 병변의 치료 성적 분석 - 2022.11.10 ~ 2024.12.31
3. 과체중 또는 비만인 시험대상자에서 카그리린티드 피하(s.c.) 2.4 mg 및 세마글루티드 피하(s.c.) 2.4 mg 복합제 (카그리세마 피하 (s.c.) 2.4 mg_2.4 mg) 주 1회 투여의 유효성 및 안전성 - 2022.11.03 ~ 2026.09.07
4. 대사성 질환에서 단클론 조혈증의 역할 규명 - 2022.03.01 ~ 2023.02.28
5. 세계 최초 인슐린 의존성 당뇨인을 위한 웨어러블 인슐린 자동 주입시스템 개발 - 2022.03.01 ~ 2022.12.31
6. 대사성 질환에서 단클론 조혈증의 역할 규명 - 2021.09.01 ~ 2022.02.28
7. 제 1형 당뇨병을 가진 환자를 대상으로 센서연동형인슐린펌프(Sensor Augmented Pump) EOpatch M의 유효성과 안전성을 확보하기 위한 다기관, 단일군, 허가 후 의료기기 임상시험 - 2021.06.07 ~ 2022.07.31
8. Atorvastatin 단독요법으로 LDLC는 적절히 조절되나, TG, HDLC 수치가 적절히 조절되지 않는 복합 이상지질혈증 환자에서 YYC506의 유효성 및 안전성을 평가하기 위한 다기관 공동, 이중 눈가림, 무작위배정, 활성약 대조, 이중위약, 병행설계의 제 3상 임상시험 및 라벨 공 - 2021.04.05 ~ 2022.06.30
9. (세부, 2차, 산자부)세계 최초 인슐린 의존성 당뇨인을 위한 웨어러블 인슐린 자동 주입시스템 개발 - 2021.03.01 ~ 2022.02.28
10. 대사성 질환에서 단클론 조혈증의 역할 규명 - 2020.10.01 ~ 2022.12.31
11. (세부, 2차, 산자부)세계 최초 인슐린 의존성 당뇨인을 위한 웨어러블 인슐린 자동 주입시스템 개발 - 2020.09.01 ~ 2021.02.28
12. 대사성 질환에서 단클론 조혈증의 역할 규명 - 2020.09.01 ~ 2021.08.31
13. 새로운 아디포카인 Secreted frizzled-related protein 5 (Sfrp5)의 항동맥경화증 효과 규명 - 2017.08.01 ~ 2024.01.31

데이터가 없습니다.

      데이터가 없습니다.

 공지